Related Experiment Video

Updated: Nov 4, 2025

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.6K

Risk factors for delayed radiographic resolution in children with refractory Mycoplasma pneumoniae pneumonia

Qiuli Yan1,2, Wensi Niu2, Wujun Jiang1

  • 1Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.

The Journal of International Medical Research
|May 26, 2021
PubMed

Insights

Identifying risk factors for delayed pneumonia resolution in children is key. Early interventional bronchoscopy before 11.5 days may improve outcomes for refractory Mycoplasma pneumoniae pneumonia.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Radiology

Background:

  • Refractory Mycoplasma pneumoniae pneumonia (RMPP) presents a significant challenge in pediatric care.
  • Delayed radiographic resolution in RMPP can prolong illness and increase healthcare burden.

Purpose of the Study:

  • To identify risk factors associated with delayed radiographic resolution in pediatric RMPP.
  • To determine the optimal timing for interventional bronchoscopy in RMPP management.

Main Methods:

  • Retrospective analysis of 142 children diagnosed with RMPP between 2015 and 2017.
  • Patients were categorized into common and delayed radiographic resolution groups.
  • Statistical analysis to identify independent risk factors for delayed resolution.

Main Results:

  • Delayed resolution was linked to longer pre-bronchoscopy duration (≥11.5 days), mucus plugs, corticosteroid resistance, and atelectasis.
  • Interventional bronchoscopy before 11.5 days correlated with shorter hospitalization, reduced fever duration, and faster cough resolution.
  • Key risk factors identified for delayed resolution include mucus plug formation, corticosteroid resistance, and atelectasis.

Conclusions:

  • Corticosteroid resistance, atelectasis, mucus plug formation, and timing of interventional bronchoscopy are crucial factors in RMPP radiographic resolution.
  • Performing interventional bronchoscopy earlier, before 11.5 days of illness, can significantly improve clinical symptoms and radiographic outcomes in pediatric RMPP.
Abstract

Keywords:
Refractory Mycoplasma pneumoniae pneumoniabronchoscopychest radiographchildrenclinical coursedelayed resolution

More Related Videos

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.6K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
549
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
455
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
538
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
58